Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion type Assertion NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_head.
- NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_provenance.
- NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion evidence source_evidence_literature NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_provenance.
- NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion SIO_000772 23308200 NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_provenance.
- NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion wasDerivedFrom befree-2016 NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_provenance.
- NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion wasGeneratedBy ECO_0000203 NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_provenance.